Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized …

DE Jorenby, JT Hays, NA Rigotti, S Azoulay, EJ Watsky… - Jama, 2006 - jamanetwork.com
… Dr Hays reported receiving a research grant from Pfizer. Dr Rigotti reported receiving
research grant funding and consulting fees from GlaxoSmithKline, which markets smoking …

Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation: a randomized, controlled trial

JT Hays, RD Hurt, NA Rigotti, R Niaura… - Annals of internal …, 2001 - acpjournals.org
Background: Smoking relapse is common after successful pharmacologic treatment for
smoking cessation. No previous studies have examined long-term drug therapy used expressly …

Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial

DP Tashkin, S Rennard, JT Hays, W Ma, D Lawrence… - Chest, 2011 - Elsevier
… Dr Hays received a research grant from Pfizer Inc for the conduct of the clinical trial described
in this manuscript. In the past 3 years, Dr Rennard has been a consultant or a member of …

Varying nicotine patch dose and type of smoking cessation counseling

…, MC Fiore, RD Hurt, KP Offord, IT Croghan, JT Hays… - Jama, 1995 - jamanetwork.com
Objective. —To compare the efficacy and safety of 22-mg and 44-mg doses of transdermal
nicotine therapy when it is paired with minimal, individual, or group counseling to improve …

Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial

…, IT Croghan, DR Schroeder, SS Allen, JT Hays… - Jama, 2014 - jamanetwork.com
… Dr Hays reports serving as an investigator for clinical trials funded by Pfizer. Dr Hurt reports
receipt of consulting fees from Pfizer, an unrestricted grant from Pfizer Medical Education …

Varenicline for tobacco dependence

JT Hays, JO Ebbert - New England Journal of Medicine, 2008 - Mass Medical Soc
A 57-year-old man presents to his primary care provider because he would like to quit
smoking. A trial of varenicline, a partial agonist of the nicotinic acetylcholine receptor that has …

Cardiovascular safety of varenicline, bupropion, and nicotine patch in smokers: a randomized clinical trial

NL Benowitz, A Pipe, R West, JT Hays… - JAMA internal …, 2018 - jamanetwork.com
… Dr Hays has received research support from Pfizer for the conduct of this study. Dr Tonstad
has received honoraria for lectures and consulting for Pfizer. Drs McRae, Lawrence, and St …

The efficacy and safety of varenicline for smoking cessation using a flexible dosing strategy in adult smokers: a randomized controlled trial

R Niaura, JT Hays, DE Jorenby, FT Leone… - … medical research and …, 2008 - Taylor & Francis
Objective: To determine whether self-regulated flexible dosing with varenicline tartrate is safe
and effective for smoking cessation. Research design and methods: 320 healthy, motivated…

Relationship between organizational leadership and health care employee burnout and satisfaction

LN Dyrbye, B Major-Elechi, JT Hays, CH Fraser… - Mayo Clinic …, 2020 - Elsevier
Objective To explore the relationship between immediate supervisor leadership behaviors
and burnout and professional satisfaction of health care employees. Participants and …

Varenicline and bupropion sustained-release combination therapy for smoking cessation

…, A Sood, DR Schroeder, JT Hays… - Nicotine & Tobacco …, 2009 - academic.oup.com
Introduction: Varenicline and bupropion sustained release (SR) are both safe and effective
for the treatment of tobacco dependence and have different mechanisms of action. …